Literature DB >> 3041943

Cutaneous malignant melanoma in survivors of heritable retinoblastoma.

E I Traboulsi1, L E Zimmerman, H J Manz.   

Abstract

Six survivors of bilateral retinoblastoma developed cutaneous malignant melanoma 20 to 51 years (average, 31 years) after initial therapy for the ocular tumor. Five patients received radiation therapy to the orbital area. In two patients the cutaneous malignant melanoma developed in the field of irradiation. Two patients developed multiple cutaneous melanomas and are thought to have the dysplastic nevus syndrome. At this writing two patients are alive and well after wide resection of their skin tumors. A review of the literature suggests that cutaneous malignant melanoma accounts for about 7% of second malignant neoplasms in survivors of heritable retinoblastoma.

Entities:  

Mesh:

Year:  1988        PMID: 3041943     DOI: 10.1001/archopht.1988.01060140215026

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

1.  Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma.

Authors:  Ichiro Okamoto; Christine Pirker; Martin Bilban; Walter Berger; Doris Losert; Christine Marosi; Oskar A Haas; Klaus Wolff; Hubert Pehamberger
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

2.  Preimplantation genetic diagnosis for retinoblastoma predisposition.

Authors:  Seema Dhanjal; Georgia Kakourou; Thalia Mamas; Natasha Saleh; Alpesh Doshi; Sarah Gotts; Sarah Nuttall; Karen Fordham; Paul Serhal; Joy Delhanty; Joyce Harper; Sioban Sengupta
Journal:  Br J Ophthalmol       Date:  2007-08       Impact factor: 4.638

3.  Excess naevi after chemotherapy in childhood.

Authors:  M M Hawkins; J E Kingston; L M Wilson
Journal:  BMJ       Date:  1989-08-05

Review 4.  Hereditary melanoma and the search for the melanoma gene.

Authors:  R F Kefford
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

5.  Malignant fibrous histiocytoma in a patient with history of treated retinoblastoma.

Authors:  Hind M Alkatan; Azzah Maktabi
Journal:  Saudi J Ophthalmol       Date:  2010-01-04

Review 6.  Melanoma Genomics.

Authors:  Julia Newton-Bishop; D Timothy Bishop; Mark Harland
Journal:  Acta Derm Venereol       Date:  2020-06-03       Impact factor: 3.875

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.